Check your medicine cabinets.
More than 11,100 bottles of a type of blood pressure medication sold under the brand name Ziac are being recalled due to cross-contamination with other medications, according to the U.S. Food and Drug Administration.
According to the FDA, the New Jersey-based Glenmark Pharmaceuticals recalled 11,136 bottles of bisoprolol fumarate and hydrochlorothiazide tablets because they had “traces of ezetimibe (a drug used to treat high cholesterol).”
No adverse effects have been reported to date.
READ MORE: FDA recalls 580K bottles of this blood pressure medication: Is your medicine on the list?
Here’s what you need to know about the recalled tablets — and what you should do if you have the recalled medication.
What Ziac tablets were subject to the recall?
According to the FDA, the affected Ziac tablets came in 2.5 mg and 6.25 mg doses and were packaged in the following amounts:
- 30-count bottles NDC 68462-878-30
- 100-count bottle NDC-68462-878-01
- 500-count bottles NDC68462-878-05
The lot numbers of the affected medications include:
- Lot No. 17232401, exp 11/2025
- Lot No. 17240974, exp 05/2026
- Lot No. 17232401, exp 11/2025
- Lot No. 17240974, exp 05/2026
- Lot No. 17232401, exp 11/2025
- Lot No. 17240974, exp 05/2026
The FDA classified this recall as a Class III recall on Dec. 1, after it initially announced the recall on Nov. 21.
The FDA defines a Class III recall of a product as something that is “is not likely to cause adverse health consequences.”
If people believe they have the recalled Ziac tablets in their medicine cabinets, they should contact a health care provider before taking any further doses of the medication.